| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 07/06/2006 | WO2006053784A3 1,7-naphthyridines as pde4 inhibitors |
| 07/06/2006 | WO2006018727A3 Triazolopyridine compounds useful for the treatment of inflammation |
| 07/06/2006 | WO2006017672A3 2, 8-disubstituted naphthyridine derivatives |
| 07/06/2006 | WO2005105799A8 Dialkoxy-imidazopyridines derivatives |
| 07/06/2006 | US20060149069 2-Aminoprotected pyridine derivative is cyclized under heating to 5,6,7,8-tetrahydro-9H-pyrido[2,3-b]azepine or 1,2,3,4-tetrahydro-1,8-naphthyridine derivative; chemical intermediates; deblocking, deprotecting |
| 07/06/2006 | US20060149059 Phthalazinone derivatives |
| 07/06/2006 | US20060148852 Visual function disorder improving agents |
| 07/06/2006 | US20060148846 Crystalline forms of a factor Xa inhibitor |
| 07/06/2006 | US20060148845 In which a pyrrole ring is directly bonded to a 6,5-condensed ring system, such as a benzimidazole, imidazopyridine or imidazopyrimidine system; especially effective against drug resistant bacteria such as MRSA, PRSP, or VRE |
| 07/06/2006 | US20060148844 Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation |
| 07/06/2006 | US20060148840 Pyrrolodihydroisoquinolines as pde10 inhibitors |
| 07/06/2006 | US20060148838 Novel pyrrolodihydroisoquinolines useful in the treatment of cancer |
| 07/06/2006 | US20060148831 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 07/06/2006 | US20060148818 Novel tetraydrospiro(piperdine-2,7'- pyrrolo{3,2-b}pyridine derivatives and novel in-dole derivatives useful in the treatment of 5-ht6 receptor-related disorders |
| 07/06/2006 | US20060148809 For the therapy of deleterious neurological complaints; anxiolytic agents;cognitive disorders; good affinity as ligands for the alpha 2 and or alpha 3 and or alpha 5 subunit of the human GABAA receptor; 3-(6-Phenylpyridazin-4-yl)thiophene-2-carboxylic Acid Methyl Ester |
| 07/06/2006 | US20060148808 N'-methyl-2-[(p-fluorophenyl)-4-oxo-butyl]piperazino[1,2-fg]gamma-carboline; N'-methyl-2-[p-fluorophenoxypropyl]piperazino[1,2-fg]gamma-carboline; serotonin modulators; sleep disorders; central nervous system disorders |
| 07/06/2006 | US20060148806 Quinolone derivative or salt thereof |
| 07/06/2006 | US20060148805 Opthalmic compositions for treating ocular hypertension |
| 07/06/2006 | US20060148789 Novel diazabicyclic aryl derivatives |
| 07/06/2006 | US20060148649 Substituted n-aryl nitrogen heterocycles |
| 07/06/2006 | US20060145122 Europium compounds and ink compositions containing the same |
| 07/06/2006 | DE102004060659A1 Neue substituierte 1H-Pyrrolo[2,3-b]pyridine und deren Herstellung New substituted 1H-pyrrolo [2,3-b] pyridines and their production |
| 07/06/2006 | CA2594241A1 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment |
| 07/06/2006 | CA2592898A1 Polymorphs of 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate |
| 07/06/2006 | CA2592514A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 07/06/2006 | CA2587348A1 Organic compounds |
| 07/06/2006 | CA2582162A1 A process for preparation of 4-amino-1-isobutyl-1h-imidazo[4,5-c]-quinoline (imiquimod) |
| 07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
| 07/05/2006 | EP1675859A1 Modulators of serotonin receptors |
| 07/05/2006 | EP1675858A2 5-aryl-pyrazolo [4,3-d] pyrimidines, pyridines, and pyrazines and related compounds |
| 07/05/2006 | EP1675856A1 Novel tetraydrospiro{piperidine-2,7'-pyrrolo [3,2]pyridine} derivatives and novel indole derivatives useful in the treatment of 5-ht6 receptor -related disorders |
| 07/05/2006 | EP1675855A1 4-amino-quinoline ouinolizidinyl-and quinolizidinylalkyl-derivatives with antimalarial activity |
| 07/05/2006 | EP1675854A1 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 07/05/2006 | EP1675853A1 Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors |
| 07/05/2006 | EP1675852A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 07/05/2006 | EP1675847A2 Spirocyclic heterocyclic derivatives and methods of their use |
| 07/05/2006 | EP1675837A2 Benzo [1,2,5] thiadiazole compounds as cck2 modulators |
| 07/05/2006 | EP1675587A2 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain |
| 07/05/2006 | EP1675585A2 Large conductance calcium-activated k channel opener |
| 07/05/2006 | EP1675552A2 Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors |
| 07/05/2006 | EP1401440A4 Methods of use of fluoroquinolone compounds against bacteria |
| 07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/05/2006 | EP1377575B1 Antiviral pyrazolopyridine compounds |
| 07/05/2006 | EP1313739B1 Alkylated imidazopyridine derivatives |
| 07/05/2006 | EP1250328B1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 07/05/2006 | CN1798747A Kondensierte pyrazol derivate als protein kinase inhibitoren |
| 07/05/2006 | CN1798746A Reverse-turn mimetics and method relating thereto |
| 07/05/2006 | CN1262541C Tricyclic protein kinase inhibitors |
| 07/04/2006 | US7071336 Process for manufacturing opioid analgesics |
| 07/04/2006 | US7071225 Arylaminopropane analogues and their use for the treatment of glaucoma |
| 07/04/2006 | US7071209 Cyclization while heating in solvent in presence of strong acid; methylation in presence of a base; purity |
| 07/04/2006 | US7071208 β3 Adrenergic agonists |
| 07/04/2006 | US7071207 Suppression appetite; induction weight loss |
| 07/04/2006 | US7071204 Antitumor agents; topoisomerase inhibitor; leukemia therapy |
| 07/04/2006 | US7071195 Especially amino- or amido-ethyltetralin derivatives |
| 07/04/2006 | US7071192 Respiratory system disorders; infections in infants |
| 07/04/2006 | US7071191 Non-imidazole aryloxypiperidines |
| 07/04/2006 | US7071187 Naphthyridine derivatives |
| 07/04/2006 | US7071186 Drug abuse; antiserotonine agents; central nervous system disorders; sleep disorders |
| 07/04/2006 | US7071185 Treating schizophrenia with no weight-gain side effects; 5-HT2c recptor agonist; bipolar disorder; antidepressants; anxiolytic agents; panic attack; agoraphobia; antiepileptic agents; sleep disorders; migraines; sexual dysfunction |
| 07/04/2006 | US7070766 Delivery of physiologically active compounds through an inhalation route |
| 07/04/2006 | US7070765 condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing the vapor; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns. |
| 07/04/2006 | US7070764 Delivery of analgesics through an inhalation route |
| 07/04/2006 | US7070763 Delivery of diphenhydramine through an inhalation route |
| 07/04/2006 | US7070762 Delivery of analgesics through an inhalation route |
| 07/04/2006 | US7070761 Aerosols; heating, vaporization, cooling |
| 07/04/2006 | CA2332066C Tetrazole compounds as thyroid receptor ligands |
| 07/04/2006 | CA2233285C Pyrazolopyrimidines as crf receptor antagonists |
| 06/29/2006 | WO2006069258A1 Substituted heterocyclic compounds and methods of use |
| 06/29/2006 | WO2006069193A2 Imidazo[4,5-c]pyridine compound and method of antiviral treatment |
| 06/29/2006 | WO2006069162A1 Novel heterocyclic compounds and their pharmaceutical compositions |
| 06/29/2006 | WO2006069080A2 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors |
| 06/29/2006 | WO2006068617A1 A new manufacturing process for the preparation of halogen substituted 4-hydroxy-2-(2-chloro-4-methylphenyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione |
| 06/29/2006 | WO2006068164A1 Tricyclic compound and use thereof |
| 06/29/2006 | WO2006067614A2 Heteroaromatic derivatives useful as anticancer agents |
| 06/29/2006 | WO2006067584A1 8-aza-bicyclo (3.2.1) octane derivatives with an activity on chemokine ccr5 receptors |
| 06/29/2006 | WO2006067532A1 G-protein coupled receptor agonists |
| 06/29/2006 | WO2006066955A1 Quinoline derivative, use and production thereof, and drug containing the same |
| 06/29/2006 | WO2006066414A1 Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase |
| 06/29/2006 | US20060142590 Asymmetric BIS (indolestyryl) compound and high density recording media utilizing the same |
| 06/29/2006 | US20060142347 Compounds and methods for the treatment or prevention of Flavivirus infections |
| 06/29/2006 | US20060142330 e.g. 4-chloro-3-(phenylsulfonyl)-1-(piperidin-4-ylmethyl)-1H-pyrazolo[4,3-b]pyridineI; antidepressant, anxiolytic agent, cognition activator; Alzheimer's and attention deficit disorder, schizophrenia, obsessive compulsive disorders, |
| 06/29/2006 | US20060142329 Substituted fused N-heteroaryl compounds such as imidazo[1,5a]- or [1,2s]pyridines, e.g., 3-[3-(Pyrrolylphenoxy-2-hydroxypropyl)aminoalkyl]imidazo[1,5-a]pyridine derivatives, especially HCl salts; treating obesity and type 2 diabetes |
| 06/29/2006 | US20060142328 Beta 3 adrenergic agonists |
| 06/29/2006 | US20060142327 Beta 3 adrenergic agonists |
| 06/29/2006 | US20060142324 Aryl fused 2,4-disubstituted pyridines: NK3 receptor ligands |
| 06/29/2006 | US20060142322 2-Alkyl/aryl sulphonyl-1,2,3,4-tetrahydro-9H-pyrido (3,4-b) indole-3-carboxylic acid esters/amides useful as antithrombotic agents |
| 06/29/2006 | US20060142321 2-[1-(5-Chloro-2,4-difluoro-benzenesulfonyl)-piperidin-4-ylmethyl]-1,2,3,4-tetrahydroisoquinolinehydrochloride; antidepressant, anxiolytic, hypotensive agent; psychosis, schizophrenia, migraine, cognition activity; pharmacokinetics |
| 06/29/2006 | US20060142301 Substituted 1-benzyl-4-substituted piperazine analogues |
| 06/29/2006 | US20060142298 Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents |
| 06/29/2006 | US20060142266 Compounds and their uses |
| 06/29/2006 | US20060142262 4-[1-(4-Methanesulfonyl-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy]-piperidine-1-carboxylic acid tert-butyl ester, for example, as antidiabetic and antiobesity agents |
| 06/29/2006 | US20060142247 Tricyclic heterocycles |
| 06/29/2006 | US20060141284 Material for organic electroluminescence element, and organic electroluminescence element using the same |
| 06/29/2006 | US20060138408 Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof |
| 06/29/2006 | DE102004061288A1 New 3-amino-pyrazolo(3,4b)pyridine derivatives are protein tyrosine kinases inhibitors useful e.g. for treating hyperproliferation of body cells, neurodegenerative disease, blood vessel disease and angiogenic disease |
| 06/29/2006 | CA2634499A1 Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase |
| 06/29/2006 | CA2594602A1 8-aza-bicyclo (3.2.1) octane derivatives with an activity on chemokine ccr5 receptors |
| 06/29/2006 | CA2592388A1 Imidazo[4,5-c]pyridine compound and method of antiviral treatment |
| 06/29/2006 | CA2592119A1 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as janus kinase inhibitors |